Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rhodes LV"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
Autorzy:
Matossian MD; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Elliott S; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Rhodes LV; Department of Biology, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Martin EC; Department of Biological and Agricultural Engineering Biology, Louisiana State University, Baton Rouge, LA 70803, USA.
Hoang VT; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Burks HE; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Zuercher WJ; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Drewry DH; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Collins-Burow BM; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Burow ME; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 May; Vol. 21 (5), pp. 380. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Autorzy:
Matossian MD; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.
Burks HE; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.
Elliott S; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.
Hoang VT; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.
Bowles AC; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA.
Sabol RA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA.
Wahba B; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.
Anbalagan M; Department of Structural and Cellular Biology, Tulane University, New Orleans, LA, USA.
Rowan B; Department of Structural and Cellular Biology, Tulane University, New Orleans, LA, USA.
Abazeed ME; Cleveland Clinic, Department of Radiation Oncology, Cleveland, OH, USA.
Bunnell BA; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA.
Moroz K; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA.; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.
Miele L; Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Rhodes LV; Department of Biology, Florida Gulf Coast University, Fort Myers, FL, USA.
Jones SD; Tulane Cancer Center, New Orleans, LA, USA.; Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
Martin EC; Department of Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA.
Collins-Burow BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Cancer Center, New Orleans, LA, USA.
Burow ME; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA. .; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA. .; Tulane Cancer Center, New Orleans, LA, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Mar 07; Vol. 19 (1), pp. 205. Date of Electronic Publication: 2019 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
Drug Resistance, Neoplasm/*genetics
Triple Negative Breast Neoplasms/*genetics
Animals ; Biomarkers ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Fluorescent Antibody Technique ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Immunohistochemistry ; Mice ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Triple Negative Breast Neoplasms/drug therapy ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
Autorzy:
Martin EC
Rhodes LV
Elliott S
Krebs AE
Nephew KP
Flemington EK
Collins-Burow BM
Burow ME; Department of Medicine-Section of Hematology and Medical Oncology, Tulane University, New Orleans, LA, USA. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2014 Oct 06; Vol. 13, pp. 229. Date of Electronic Publication: 2014 Oct 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Estrogen Receptor alpha/*metabolism
MicroRNAs/*metabolism
Sirolimus/*analogs & derivatives
TOR Serine-Threonine Kinases/*metabolism
Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Estrogen Receptor alpha/genetics ; Estrogens/pharmacology ; Everolimus ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; MCF-7 Cells ; Mechanistic Target of Rapamycin Complex 1 ; Mechanistic Target of Rapamycin Complex 2 ; Mice ; MicroRNAs/genetics ; Multiprotein Complexes/metabolism ; Phenotype ; Phosphorylation/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; Receptors, Progesterone/metabolism ; Signal Transduction/genetics ; Sirolimus/pharmacology
Czasopismo naukowe
Tytuł:
MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.
Autorzy:
Antoon JW; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Martin EC
Lai R
Salvo VA
Tang Y
Nitzchke AM
Elliott S
Nam SY
Xiong W
Rhodes LV
Collins-Burow B
David O
Wang G
Shan B
Beckman BS
Nephew KP
Burow ME
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Aug 09; Vol. 8 (8), pp. e69291. Date of Electronic Publication: 2013 Aug 09 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Breast Neoplasms/*genetics
Carcinoma/*genetics
Estrogen Receptor alpha/*genetics
MAP Kinase Kinase 5/*genetics
Mitogen-Activated Protein Kinase 7/*genetics
Animals ; Antineoplastic Agents, Hormonal/pharmacology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Carcinogenesis/pathology ; Carcinoma/metabolism ; Carcinoma/pathology ; Cell Line, Tumor ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Epithelial-Mesenchymal Transition/genetics ; Estradiol/analogs & derivatives ; Estradiol/pharmacology ; Estrogen Receptor alpha/metabolism ; Estrogens/metabolism ; Female ; Fulvestrant ; Gene Expression Profiling ; Humans ; MAP Kinase Kinase 5/metabolism ; Mice ; Mitogen-Activated Protein Kinase 7/antagonists & inhibitors ; Mitogen-Activated Protein Kinase 7/metabolism ; Neoplasms, Experimental ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.
Autorzy:
Martin EC; Department of Medicine-Section of Hematology and Medical Oncology, Tulane University, New Orleans, LA, USA.
Bratton MR
Zhu Y
Rhodes LV
Tilghman SL
Collins-Burow BM
Burow ME
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (11), pp. e49067. Date of Electronic Publication: 2012 Nov 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*genetics
Carcinoma/*genetics
Gene Expression Regulation, Neoplastic/*drug effects
Insulin-Like Growth Factor I/*metabolism
MicroRNAs/*genetics
Signal Transduction/*drug effects
Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Carcinoma/metabolism ; Carcinoma/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Female ; Gene Expression Profiling ; Humans ; Insulin-Like Growth Factor I/genetics ; Insulin-Like Growth Factor I/pharmacology ; MicroRNAs/metabolism ; Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors ; Mitogen-Activated Protein Kinase Kinases/genetics ; Mitogen-Activated Protein Kinase Kinases/metabolism ; Oligonucleotide Array Sequence Analysis ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins c-akt/antagonists & inhibitors ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Real-Time Polymerase Chain Reaction
Czasopismo naukowe
Tytuł:
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.
Autorzy:
Tilghman SL; Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, Louisiana, United States of America.
Bratton MR
Segar HC
Martin EC
Rhodes LV
Li M
McLachlan JA
Wiese TE
Nephew KP
Burow ME
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (3), pp. e32754. Date of Electronic Publication: 2012 Mar 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Breast Neoplasms/*pathology
DDT/*pharmacology
Endocrine Disruptors/*pharmacology
Gene Expression Regulation, Neoplastic/*drug effects
MicroRNAs/*genetics
Phenols/*pharmacology
Benzhydryl Compounds ; Breast Neoplasms/genetics ; Cell Line, Tumor ; Estrogen Receptor alpha/metabolism ; Estrogens/metabolism ; Humans ; Transcription, Genetic/drug effects ; Transcriptome/drug effects
Czasopismo naukowe
Tytuł:
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Autorzy:
Rhodes LV; Department of Medicine, Section of Haematology and Medical Oncology, Tulane University Health Science Centre, New Orleans, Louisiana, USA. />Antoon JW
Muir SE
Elliott S
Beckman BS
Burow ME
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2010 Nov 18; Vol. 9, pp. 295. Date of Electronic Publication: 2010 Nov 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Breast Neoplasms/*metabolism
Carcinoma/*metabolism
Chemokine CXCL12/*metabolism
Mesenchymal Stem Cells/*metabolism
Receptors, CXCR4/*metabolism
Receptors, Estrogen/*metabolism
Benzylamines ; Breast Neoplasms/pathology ; Cell Differentiation/genetics ; Cell Differentiation/physiology ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Movement/physiology ; Cell Proliferation/drug effects ; Cells, Cultured ; Chemokine CXCL12/genetics ; Chemokine CXCL12/pharmacology ; Coculture Techniques ; Cyclams ; Female ; Flow Cytometry ; Heterocyclic Compounds/pharmacology ; Humans ; Microscopy, Fluorescence ; Receptors, CXCR4/antagonists & inhibitors ; Receptors, Estrogen/antagonists & inhibitors ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction/drug effects
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies